Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia

Background. The risk of infection associated with specific treatments of chronic active antibody-mediated rejection (cAMR) after kidney transplantation remains unknown. Methods. This was a single-center study of kidney transplant recipients treated with pulse steroids, intravenous immunoglobulin (IV...

Full description

Bibliographic Details
Main Authors: Emily Joachim, MD, Sandesh Parajuli, MBBS, Kurtis J. Swanson, MD, Fahad Aziz, MBBS, Neetika Garg, MBBS, Maha Mohamed, MD, Didier Mandelbrot, MD, Arjang Djamali, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001080

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001080

Similar Items